MediFind found 6 doctor with experience in Chronic B-Cell Leukemia (CBCL) near Shizuoka, JP. Of these, 6 are Experienced.
Yoshikane Kikushige practices in Higashi, Japan. Kikushige is rated as an Experienced expert by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). Their top areas of expertise are Leukemia, Acute Myeloid Leukemia (AML), Small Lymphocytic Lymphoma (SLL), Chronic B-Cell Leukemia (CBCL), and Bone Marrow Transplant.
Ilseung Choi practices in Fukuoka, Japan. Choi is rated as an Experienced expert by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). Their top areas of expertise are Adult T-Cell Leukemia, Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Bone Marrow Transplant, and Vitrectomy.
Koji Kato practices in Fukuoka, Japan. Mr. Kato is rated as an Experienced expert by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Adult T-Cell Leukemia, Non-Hodgkin Lymphoma, B-Cell Lymphoma, Bone Marrow Transplant, and Bone Graft.
Koichi Ohshima practices in Kurume, Japan. Mr. Ohshima is rated as an Experienced expert by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Adult T-Cell Leukemia, Non-Hodgkin Lymphoma, B-Cell Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.
Tomohiko Kamimura practices in Fukuoka, Japan. Kamimura is rated as an Experienced expert by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). Their top areas of expertise are Graft Versus Host Disease (GvHD), Leukemia, Acute Lymphoblastic Leukemia (ALL), Bone Marrow Transplant, and Splenectomy.
Masaru Tanaka practices in Fukuoka, Japan. Mr. Tanaka is rated as an Experienced expert by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are COVID-19, Pyridoxine Deficiency, Severe Acute Respiratory Syndrome (SARS), Thrombectomy, and Percutaneous Coronary Intervention (PCI).
To see more doctors, please expand your search radius or view related conditions below.
Last Updated: 01/09/2026